Efficacy and safety of reduced-dose daratumumab plus bortezomib and dexamethasone (DVd-lite) in newly diagnosed MGRS patients.
Saved in:
| Title: | Efficacy and safety of reduced-dose daratumumab plus bortezomib and dexamethasone (DVd-lite) in newly diagnosed MGRS patients. |
|---|---|
| Authors: | Xie H; Department of Hematology, Daping Hospital, Army Medical University, Chongqing, China., Xiang M; Department of Hematology, Daping Hospital, Army Medical University, Chongqing, China., Zhang M; Department of Hematology, Daping Hospital, Army Medical University, Chongqing, China., Meng F; Department of Hematology, Daping Hospital, Army Medical University, Chongqing, China., Qi Y; Department of Hematology, Daping Hospital, Army Medical University, Chongqing, China., Chen K; Department of Nephrology, Daping Hospital, Army Medical University, Chongqing, China., Zeng D; Department of Hematology, Daping Hospital, Army Medical University, Chongqing, China. |
| Source: | Frontiers in immunology [Front Immunol] 2026 Jun 23; Vol. 17, pp. 1722204. Date of Electronic Publication: 2026 Jun 23 (Print Publication: 2026). |
| Publication Type: | Clinical Trial; Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2026.1722204 |
